Table of Contents

Opioid Withdrawal

Primer

Opioid Withdrawal is a withdrawal syndrome that develops after stopping or reducing opioid use that has been heavy and prolonged. Opioid withdrawal can also be triggered by administration of an opioid antagonist (e.g. - naloxone or naltrexone) after a period of opioid use.

Epidemiology
Prognosis
Risk Factors

DSM-5 Diagnostic Criteria

Criterion A

Presence of either of the following:

  1. Cessation of (or reduction in) opioid use that has been heavy and prolonged (i.e. - several weeks or longer).
  2. Administration of an opioid antagonist after a period of opioid use.
Criterion B

At least 3 of the following developing within minutes to several days after Criterion A:

  1. Dysphoric mood
  2. Nausea or vomiting
  3. Muscle aches
  4. Lacrimation or rhinorrhea
  5. Pupillary dilation, piloerection, or sweating
  6. Diarrhea
  7. Yawning
  8. Fever
  9. Insomnia
Criterion C

The signs or symptoms in Criterion B cause clinically significant distress or impairment in social, occupational, or other important areas of functioning.

Criterion D

The signs or symptoms are not attributable to another medical condition and are not better explained by another mental disorder, including intoxication or withdrawal from another substance.

Signs and Symptoms

Screening and Rating Scales

Clinical Opioid Withdrawal Scale (COWS)

Scales for Opioid Withdrawal

Name Rater Description Download
Clinical Opioid Withdrawal Scale (COWS) Clinician An 11-item scale designed to be administered by a clinician. This can be used in both inpatient/outpatient settings to reproducibly rate and monitor common signs and symptoms of opiate withdrawal. COWS Download

Pathophysiology

Differential Diagnosis

Investigations

Physical Exam

Treatment

Symptom Management

Acute Withdrawal Management

Methadone

Suboxone

Guidelines

Opioid Use Disorder Guidelines

Guideline Location Year PDF Website
Canadian Medical Association Journal (CMAJ) Canada 2018 - Link
BC Centre on Substance Use (BCCSU) Canada 2023 Link Link
META:PHI Canada 2019 Link Link
Canadian Guidelines on Opioid Use Disorder Among Older Adults Canada 2020 PDF Link
National Institute for Health and Care Excellence (NICE) UK 2007 - Link
American Psychiatric Association USA 2006, 2007 - Guideline (2006)
Guideline Watch (2007)
Quick Reference

Resources

For Patients
For Providers
Articles
Research
1) American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Arlington, VA.
2) American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Arlington, VA.
3) American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Arlington, VA.
6) American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Arlington, VA.